GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (FRA:1FW2) » Definitions » Pretax Margin %

WuXi Biologics (Cayman) (FRA:1FW2) Pretax Margin % : 19.26% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is WuXi Biologics (Cayman) Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. WuXi Biologics (Cayman)'s Pre-Tax Income for the six months ended in Dec. 2023 was €211 Mil. WuXi Biologics (Cayman)'s Revenue for the six months ended in Dec. 2023 was €1,097 Mil. Therefore, WuXi Biologics (Cayman)'s pretax margin for the quarter that ended in Dec. 2023 was 19.26%.

The historical rank and industry rank for WuXi Biologics (Cayman)'s Pretax Margin % or its related term are showing as below:

FRA:1FW2' s Pretax Margin % Range Over the Past 10 Years
Min: 11.74   Med: 26.39   Max: 38.81
Current: 24.5


FRA:1FW2's Pretax Margin % is ranked better than
89.83% of 1032 companies
in the Biotechnology industry
Industry Median: -167.31 vs FRA:1FW2: 24.50

WuXi Biologics (Cayman) Pretax Margin % Historical Data

The historical data trend for WuXi Biologics (Cayman)'s Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi Biologics (Cayman) Pretax Margin % Chart

WuXi Biologics (Cayman) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.28 35.03 38.81 35.09 24.50

WuXi Biologics (Cayman) Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.89 40.66 30.11 29.78 19.26

Competitive Comparison of WuXi Biologics (Cayman)'s Pretax Margin %

For the Biotechnology subindustry, WuXi Biologics (Cayman)'s Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WuXi Biologics (Cayman)'s Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WuXi Biologics (Cayman)'s Pretax Margin % distribution charts can be found below:

* The bar in red indicates where WuXi Biologics (Cayman)'s Pretax Margin % falls into.



WuXi Biologics (Cayman) Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

WuXi Biologics (Cayman)'s Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=536.032/2187.671
=24.50 %

WuXi Biologics (Cayman)'s Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=211.241/1097.057
=19.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WuXi Biologics (Cayman)  (FRA:1FW2) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


WuXi Biologics (Cayman) Pretax Margin % Related Terms

Thank you for viewing the detailed overview of WuXi Biologics (Cayman)'s Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


WuXi Biologics (Cayman) (FRA:1FW2) Business Description

Address
No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092
WuXi Biologics is one of the largest global biologics CRDMOs. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 15 billion. North American represented 55.6% of total revenue in 2022. It adopts the follow and win the molecule strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual-sourcing strategy by providing drug products and large-scale drug substance manufacturing.

WuXi Biologics (Cayman) (FRA:1FW2) Headlines

No Headlines